Grow Therapy
Healthcare · AI
Grow Therapy Raises $150M Series D at $3B Valuation
March 3, 2026$150M · Series D
Grow Therapy secured $150 million in Series D funding led by TCV and Goldman Sachs Alternatives, achieving a $3 billion valuation amid $1 billion annual revenue. The round supports expanded employer and health system partnerships to enhance mental health access.
Lead Investors
TCVGoldman Sachs
Read the Full Story in Velocity
Get curated startup and tech news with new stories published daily, company insights, and real-time alerts.